As Big Pharma Eye Big Buyouts In India, Merck KGaA Goes With Bangalore Genei To Sharpen Edge In Biologicals
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Away from the high decibel market speculation about moves made by Big Pharma to acquire large-sized companies in India, Darmstadt, Germany-headquartered Merck KGaA quietly picked up a little known molecular biology company called Bangalore Genei, which it claimed will help it "become one of the leading bioscience companies in India.